Biggest News Aggregation in the World

Pascal Nigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascal Nigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascal Nigen Today - Breaking & Trending Today

NLS Pharmaceutics AG: NLS Pharmaceutics Announces $4 Million Private Placement and Conversion of Existing Short-Term Notes

Published: October 3, 2022

ZURICH, SWITZERLAND / ACCESSWIRE / October 3, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and

Source: finanznachrichten.de

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Positive Top-Line Results from its Phase 2a Clinical Trial of Once-Daily Quilience for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

Published: September 27, 2022

Statistically significant results with Quilience® (Mazindol ER) achieving a 7.1 point mean reduction in ESS from baseline compared to a 3.2 point reduction for placebo, p=0.0081Fast onset of action from

Source: finanznachrichten.de

NLS Pharmaceutics AG: NLS Pharmaceutics To Host Virtual Key Opinion Leader Event on September 30, 2022 After Release of Quilience Top-Line Phase 2a Narcolepsy Results

Published: September 19, 2022

ZURICH, SWITZERLAND / ACCESSWIRE / September 19, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP), (Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

Source: finanznachrichten.de

NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Dr. George Apostol as Chief Medical Officer and Global Head of Research & Development

Published: September 8, 2022

Company also announces expected departure of Sylvia Panigone, Ph.D.ZURICH, SWITZERLAND / ACCESSWIRE / September 8, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage

Source: finanznachrichten.de

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Receipt of NASDAQ Minimum Bid Price Notification

Published: June 10, 2022

ZURICH, SWITZERLAND / ACCESSWIRE / June 10, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP),(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

Source: finanznachrichten.de